Literature DB >> 2771063

Ocular pseudomyasthenia or ocular myasthenia 'plus': a warning to clinicians.

G Moorthy1, M M Behrens, D B Drachman, T H Kirkham, D L Knox, N R Miller, T L Slamovitz, S J Zinreich.   

Abstract

Myasthenia gravis (MG) commonly presents with weakness and fatigability of the lids and extraocular muscles, which respond to treatment with anticholinesterase medication. However, certain intracranial mass lesions may mimic these features of MG; alternatively, MG may mask the signs of a coexistent intracranial mass. We describe 8 patients originally diagnosed as having MG by knowledgeable clinicians, in whom an intracranial lesion instead of, or in addition to, MG was later identified. The lesions included parasellar tumors and aneurysms. In patients presenting with clinical features of ocular MG, it is therefore essential to establish a definite diagnosis of MG, to exclude other possible causes of "pseudomyasthenia," and to exclude other diseases that might be masked by coexisting myasthenic weakness. We recommend that patients with clinical features of MG limited to the ocular or cranial musculature be thoroughly evaluated for intracranial mass lesions, using CT or MRI if warranted.

Entities:  

Mesh:

Year:  1989        PMID: 2771063     DOI: 10.1212/wnl.39.9.1150

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

Authors:  N Sommer; B Sigg; A Melms; M Weller; K Schepelmann; V Herzau; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

2.  [Stress-related vertical double vision and ptosis].

Authors:  A M Palmowski-Wolfe; L Kappos; J Müller-Brand; C Buitrago-Tellez; A Merlo
Journal:  Ophthalmologe       Date:  2009-01       Impact factor: 1.059

3.  Transient ptosis and miosis after rugby injury.

Authors:  S W Yusuf
Journal:  J R Soc Med       Date:  1998-02       Impact factor: 5.344

4.  Ptosis in an elderly man.

Authors:  S W Yusuf; R M Mishra
Journal:  Postgrad Med J       Date:  1997-01       Impact factor: 2.401

5.  Clinically and electrophysiologically diagnosed botulinum intoxication.

Authors:  Dilcan Kotan; Recep Aygul; Mustafa Ceylan; Yalcin Yilikoglu
Journal:  BMJ Case Rep       Date:  2013-01-03

Review 6.  Eye movements.

Authors:  S Shaunak; E O'Sullivan; C Kennard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

7.  Ocular pseudomyasthenia: report of a case with a pineal region tumor.

Authors:  B Fierro; G Croce; L Filosto; N Carbone; I Lupo
Journal:  Ital J Neurol Sci       Date:  1991-12

8.  Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.

Authors:  Crandall E Peeler; Lindsey B De Lott; Lina Nagia; Joao Lemos; Eric R Eggenberger; Wayne T Cornblath
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

Review 9.  Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.

Authors:  N Sommer; A Melms; M Weller; J Dichgans
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 10.  Myasthenia gravis.

Authors:  Vern C Juel; Janice M Massey
Journal:  Orphanet J Rare Dis       Date:  2007-11-06       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.